Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript Summary
Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript Summary
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.The following is a summary of the Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript:
以下是accelerate diagnostics, Inc. (AXDX) 2024年第三季度业绩发布会文字实录摘要:
Business Progress:
业务进展：
Accelerate Diagnostics is expanding its WAVE system and Gram-Negative testing menu with successful clinical trial progresses and site enrollments.
accelerate diagnostics正在扩展其WAVE系统和革兰氏阴性测试菜单，成功进行临床试验并招募研究网站。
Opportunities:
机会：
The ongoing development and rollout of the WAVE system represents a market expansion within the diagnostic segment, especially targeting Gram-Negative testing.
WAVE系统的持续发展和推出代表了诊断领域的市场扩张，特别针对革兰氏阴性测试。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由人工智能生成。内容准确性无法完全保证。如需更全面详情，请参阅IR网站。本文仅供投资者参考，不具有任何指导或推荐建议。
